Spatiotemporal distribution of heparan sulfate epitopes during murine cartilage growth plate development

Histochemistry and Cell Biology

Volumn 126, Issue 6, 2006, Pages 713-722

  Gomes Jr , Ronald R ^a,c   Van Kuppevelt, Toin H ^b   Farach Carson, Mary C ^a   Carson, Daniel D ^a  

^a UNIVERSITY OF DELAWARE   (United States)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Chondrogenesis; Glycosaminoglycan; Growth plate; Heparan sulfate proteoglycan

Indexed keywords

ANTIBODY; ANTIBODY CONJUGATE; DYE; EPITOPE; HEPARAN SULFATE; HEPARAN SULFATE ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIOPHAGE; BINDING AFFINITY; CARBOHYDRATE ANALYSIS; CARTILAGE; CHONDROGENESIS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DOWN REGULATION; EMBRYO; FEMALE; FEMUR; FLOUR; GROWTH PLATE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; NONHUMAN; PERICHONDRIUM; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TIBIA;

ANIMALS; CARTILAGE; CHONDROGENESIS; EPITOPES; FEMALE; GROWTH PLATE; HEPARAN SULFATE PROTEOGLYCANS; MICE; MICE, INBRED C57BL; PREGNANCY;

ALEXA; MURINAE;

EID: 33845396773     PISSN: 09486143     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00418-006-0203-4     Document Type: Article

References (51)

1. Arikawa-Hirasawa E, Watanabe H, Takami H, Hassell JR, Yamada Y (1999) Perlecan is essential for cartilage and cephalic development. Nat Genet 23:354-358
2. Ashikari S, Habuchi H, Kimata K (1995) Characterization of heparan sulfate oligosaccharides that bind to hepatocyte growth factor. J Biol Chem 270:29586-29593
3. Atha DH, Stephens AW, Rimon A, Rosenberg RD (1984a) Sequence variation in heparin octasaccharides with high affinity for antithrombin III. Biochemistry 23:5801-5812
4. Atha DH, Stephens AW, Rosenberg RD (1984b) Evaluation of critical groups required for the binding of heparin to antithrombin. Proc Natl Acad Sci USA 81:1030-1034
5. Axelsson S, Holmlund A, Hjerpe A (1992) Glycosaminoglycans in normal and osteoarthrotic human temporomandibular joint disks. Acta Odontol Scand 50:113-119
6. Baeg GH, Perrimon N (2000) Functional binding of secreted molecules to heparan sulfate proteoglycans in Drosophila. Curr Opin Cell Biol 12:575-580
7. Bernard MA, Hogue DA, Cole WG, Sanford T, Snuggs MB, Montufar-Solis D, Duke PJ, Carson DD, Scott A, Van Winkle WB, Hecht JT (2000) Cytoskeletal abnormalities in chondrocytes with EXT1 and EXT2 mutations. J Bone Miner Res 15:442-450
8. Bullock SL, Fletcher JM, Beddington RS, Wilson VA (1998) Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase. Genes Dev 12:1894-1906
9. Cano-Gauci DF, Song HH, Yang H, McKerlie C, Choo B, Shi W, Pullano R, Piscione TD, Grisaru S, Soon S, Sedlackova L, Tanswell AK, Mak TW, Yeger H, Lockwood GA, Rosenblum ND, Filmus J (1999) Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome. J Cell Biol 146:255-264
10. Chimal-Monroy J, Diaz de Leon L (1999) Expression of N-cadherin, N-CAM, fibronectin and tenascin is stimulated by TGF-beta1, beta2, beta3 and beta5 during the formation of precartilage condensations. Int J Dev Biol 43:59-67
11. Costell M, Gustafsson E, Aszodi A, Morgelin M, Bloch W, Hunziker E, Addicks K, Timpl R, Fassler R (1999) Perlecan maintains the integrity of cartilage and some basement membranes. J Cell Biol 147:1109-1122
12. Dennissen MA, Jenniskens GJ, Pieffers M, Versteeg EM, Petitou M, Veerkamp JH, van Kuppevelt TH (2002) Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies. J Biol Chem 277:10982-10986
13. Dowd CJ, Cooney CL, Nugent MA (1999) Heparan sulfate mediates bFGF transport through basement membrane by diffusion with rapid reversible binding. J Biol Chem 274:5236-5244
14. Esko JD, Selleck SB (2002) Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem 71:435-471
15. Faham S, Hileman RE, Fromm JR, Linhardt RJ, Rees DC (1996) Heparin structure and interactions with basic fibroblast growth factor. Science 271:1116-1120
16. French MM, Smith SE, Akanbi K, Sanford T, Hecht J, Farach-Carson MC, Carson DD (1999) Expression of the heparan sulfate proteoglycan, perlecan, during mouse embryogenesis and perlecan chondrogenic activity in vitro. J Cell Biol 145:1103-1115
17. Gould SE, Upholt WB, Kosher RA (1992) Syndecan 3: a member of the syndecan family of membrane-intercalated proteoglycans that is expressed in high amounts at the onset of chicken limb cartilage differentiation. Proc Natl Acad Sci USA 89:3271-3275
18. Guimond S, Turner K, Kita M, Ford-Perriss M, Turnbull J (2001) Dynamic biosynthesis of heparan sulphate sequences in developing mouse brain: a potential regulatory mechanism during development. Biochem Soc Trans 29:177-181
19. Handler M, Yurchenco PD, Iozzo RV (1997) Developmental expression of perlecan during murine embryogenesis. Dev Dyn 210:130-145
20. Hassell J, Yamada Y, Arikawa-Hirasawa E (2002) Role of perlecan in skeletal development and diseases. Glycoconj J 19:263-267
21. Inatani M, Honjo M, Oohira A, Kido N, Otori Y, Tano Y, Honda Y, Tanihara H (2002) Spatiotemporal expression patterns of N-syndecan, a transmembrane heparan sulfate proteoglycan, in developing retina. Invest Ophthalmol Vis Sci 43:1616-1621
22. Inatani M, Yamaguchi Y (2003) Gene expression of EXT1 and EXT2 during mouse brain development. Brain Res Dev Brain Res 141:129-136
23. Iozzo RV (1998) Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 67:609-652
24. Jenniskens GJ, Hafmans T, Veerkamp JH, van Kuppevelt TH (2002) Spatiotemporal distribution of heparan sulfate epitopes during myogenesis and synaptogenesis: a study in developing mouse intercostal muscle. Dev Dyn 225:70-79
25. Karsenty G, Wagner EF (2002) Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2:389-406
26. Kirn-Safran CB, Gomes RR, Brown AJ, Carson DD (2004) Heparan sulfate proteoglycans: coordinators of multiple signaling pathways during chondrogenesis. Birth Defects Res C Embryo Today 72:69-88
27. Kirsch T, Koyama E, Liu M, Golub EE, Pacifici M (2002) Syndecan-3 is a selective regulator of chondrocyte proliferation. J Biol Chem 277:42171-42177
28. Kjellen L, Lindahl U (1991) Proteoglycans: structures and interactions. Annu Rev Biochem 60:443-475
29. Koyama E, Leatherman JL, Shimazu A, Nah HD, Pacifici M (1995) Syndecan-3, tenascin-C, and the development of cartilaginous skeletal elements and joints in chick limbs. Dev Dyn 203:152-162
30. Koyama E, Shimazu A, Leatherman JL, Golden EB, Nah HD, Pacifici M (1996) Expression of syndecan-3 and tenascin-C: possible involvement in periosteum development. J Orthop Res 14:403-412
31. Li Z, Yasuda Y, Li W, Bogyo M, Katz N, Gordon RE, Fields GB, Bromme D (2004) Regulation of collagenase activities of human cathepsins by glycosaminoglycans. J Biol Chem 279:5470-5479
32. Lin X, Perrimon N (2002) Developmental roles of heparan sulfate proteoglycans in Drosophila. Glycoconj J 19:363-368
33. Lindahl U, Thunberg L, Backstrom G, Riesenfeld J, Nordling K, Bjork I (1984) Extension and structural variability of the antithrombin-binding sequence in heparin. J Biol Chem 259:12368-12376
34. Morko JP, Soderstrom M, Saamanen AM, Salminen HJ, Vuorio EI (2004) Up regulation of cathepsin K expression in articular chondrocytes in a transgenic mouse model for osteoarthritis. Ann Rheum Dis 63:649-655
35. Nakase T, Kaneko M, Tomita T, Myoui A, Ariga K, Sugamoto K, Uchiyama Y, Ochi T, Yoshikawa H (2000) Immunohistochemical detection of cathepsin D, K, and L in the process of endochondral ossification in the human. Histochem Cell Biol 114:21-27
36. Nicole S, Davoine CS, Topaloglu H, Cattolico L, Barral D, Beighton P, Hamida CB, Hammouda H, Cruaud C, White PS, Samson D, Urtizberea JA, Lehmann-Horn F, Weissenbach J, Hentati F, Fontaine B (2000) Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia). Nat Genet 26:480-483
37. Nishida K, Inoue H, Toda K, Murakami T (1995) Localization of the glycosaminoglycans in the synovial tissues from osteoarthritic knees. Acta Med Okayama 49:287-294
38. Nogami K, Suzuki H, Habuchi H, Ishiguro N, Iwata H, Kimata K (2004) Distinctive expression patterns of heparan sulfate Osulfotransferases and regional differences in heparan sulfate structure in chick limb buds. J Biol Chem 279:8219-8229
39. Perrimon N, Bernfield M (2000) Specificities of heparan sulphate proteoglycans in developmental processes. Nature 404:725-728
40. Pilia G, Hughes-Benzie RM, MacKenzie A, Baybayan P, Chen EY, Huber R, Neri G, Cao A, Forabosco A, Schlessinger D (1996) Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat Genet 12:241-247
41. Princivalle M, de Agostini A (2002) Developmental roles of heparan sulfate proteoglycans: a comparative review in Drosophila, mouse and human. Int J Dev Biol 46:267-278
42. Rantakokko J, Aro HT, Savontaus M, Vuorio E (1996) Mouse cathepsin K: cDNA cloning and predominant expression of the gene in osteoclasts, and in some hypertrophying chondrocytes during mouse development. FEBS Lett 393:307-313
43. Ruoslahti E, Yamaguchi Y (1991) Proteoglycans as modulators of growth factor activities. Cell 64:867-869
44. Salmivirta M, Lidholt K, Lindahl U (1996) Heparan sulfate: a piece of information. Faseb J 10:1270-1279
45. Sedita J, Izvolsky K, Cardoso WV (2004) Differential expression of heparan sulfate 6-O-sulfotransferase isoforms in the mouse embryo suggests distinctive roles during organogenesis. Dev Dyn 231:782-794
46. Seghatoleslami MR, Kosher RA (1996) Inhibition of in vitro limb cartilage differentiation by syndecan-3 antibodies. Dev Dyn 207:114-119
47. Shimazu A, Nah HD, Kirsch T, Koyama E, Leatherman JL, Golden EB, Kosher RA, Pacifici M (1996) Syndecan-3 and the control of chondrocyte proliferation during endochondral ossification. Exp Cell Res 229:126-136
48. Shworak NW, HajMohammadi S, de Agostini AI, Rosenberg RD (2002) Mice deficient in heparan sulfate 3-O-sulfotransferase-1: normal hemostasis with unexpected perinatal phenotypes. Glycoconj J 19:355-361
49. Tesche F, Miosge N (2004) Perlecan in late stages of osteoarthritis of the human knee joint. Osteoarthritis Cartilage 12:852-862
50. van Kuppevelt TH, Dennissen MA, van Venrooij WJ, Hoet RM, Veerkamp JH (1998) Generation and application of typespecific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney. J Biol Chem 273:12960-12966
51. Zak BM, Crawford BE, Esko JD (2002) Hereditary multiple exostoses and heparan sulfate polymerization. Biochim Biophys Acta 1573:346-355